Foursan Group is a private equity firm founded in 2000 and based in Amman, Jordan, with an additional office in London, United Kingdom. The firm specializes in investing in mid-sized growth companies across various sectors, including financial services, food and beverage, education, aviation, pharmaceuticals, telecommunications, and healthcare. Foursan Group primarily targets investment opportunities in the Middle East, with a strong emphasis on Jordan and selective engagements in the Levant and North Africa. The firm typically makes equity investments ranging from $10 million to $25 million, aiming for a majority or controlling stake and a seat on the Board of Directors of its portfolio companies. Over the past two decades, Foursan has launched multiple growth capital funds in collaboration with regional and global investors, contributing to job creation across the region, while also promoting ESG standards within its investment practices.
POLYMEDIC is a pharmaceutical company recognized for its 50 years of expertise in the field of Healthcare. The POLYMEDIC laboratories, recognized for their pharmaceutical know-how, are now a major player in the field of healthcare. This rise stems from a deep pharmaceutical legacy that began with the implantation in Morocco of the Rhône-Poulenc Rorer group, the global pharmaceutical company.